Scriptatherapeutics
Scripta Therapeutics develops therapeutics by modulating transcription factor activity to address the underlying causes of disease. The company utilizes best-in-class AI/ML models for unbiased drug discovery, mapping and predicting molecules that target disease-driving transcription factors. This approach focuses on creating disease-modifying agents, initially targeting neurodegenerative conditions like Alzheimer’s, Parkinson’s, and ALS.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Scripta Therapeutics develops therapeutics by modulating transcription factor activity to address the underlying causes of disease. The company utilizes best-in-class AI/ML models for unbiased drug discovery, mapping and predicting molecules that target disease-driving transcription factors. This approach focuses on creating disease-modifying agents, initially targeting neurodegenerative conditions like Alzheimer’s, Parkinson’s, and ALS.